Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Williams Companies Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Williams Companies Inc trades at $72.67 (market cap $88.48B). The key difference: Williams Companies Inc is far larger — about 14.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and Williams Companies Inc pays a 2.9% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Williams Companies Inc for 58 Days on average.
| IOVA | WMB | |
|---|---|---|
Market Cap | $6.04B | $88.48B |
Volume | 14,805,993 | 9,280,680 |
Sector | Health | Energy |
52-Week High | $14.82 | $79.40 |
52-Week Low | $1.81 | $56.51 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $5.97B | $119.11B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WMB trades at $72.34, up 1.23% with strong technical momentum and bullish analyst sentiment. The stock shows solid fundamentals with $11.95B revenue, 25.18% net margin, and consistent dividend growth. Recent earnings beat expectations in Q1 2026, while technical indicators signal bullish momentum with support at $71-72 levels. The company benefits from natural gas demand growth driven by AI data center expansion and maintains stable fee-based revenue streams.
Outlook remains positive with 79% analyst buy ratings and $87.27 consensus target, representing 21% upside. Key opportunities include AI-driven natural gas demand and strategic acquisitions, while risks involve energy market volatility and high debt levels. The stock offers compelling value with strong cash flow generation and dividend growth potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
